Global Hyperuricemia Market

1. Summary

The Global Hyperuricemia Market was valued at $5.6 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 8.3% CAGR, to an estimated market size of $8.3 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global hyperuricemia market comprises pharmaceutical interventions and therapeutic drugs designed to manage and lower elevated levels of serum uric acid (typically above 6.8 mg/dL). The scope includes treatments for symptomatic hyperuricemia, such as gout and kidney stones, as well as management of asymptomatic cases associated with metabolic syndrome and chronic kidney disease. It excludes non-pharmacological lifestyle modifications and general pain management not specific to urate-lowering therapy.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Hyperuricemia Market in the period 2025-30:

• The rising global prevalence of obesity and metabolic syndrome is a primary driver for increased uric acid overproduction.
• An aging global population is leading to higher rates of age-related kidney function decline, which impairs natural uric acid excretion.
• There is a significant shift toward combination therapies that simultaneously inhibit production and enhance renal excretion of urate.
• The development of Selective Uric Acid Reabsorption Inhibitors (SURI) and URAT1 inhibitors represents the fastest-growing innovation pipeline.
• Increased adoption of preventive screening and routine biochemical testing is identifying more asymptomatic patients earlier in the disease progression.
• The market is seeing a revitalization through precision medicine, focusing on genetic variants like SLC2A9 and ABCG2 that influence individual drug responses.
• Expansion of homecare services and specialty clinics is improving patient adherence to long-term urate-lowering therapy (ULT).

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments: